Anti-JNK2 peptide–siRNA nanostructures improve plaque endothelium and reduce thrombotic risk in atherosclerotic mice

Authors

Hua Pan, University of South Florida
Rohun U. Palekar, Washington University School of Medicine in St. Louis
Kirk K. Hou, Washington University School of Medicine in St. Louis
John Bacon, Washington University School of Medicine in St. Louis
Huimin Yan, Washington University School of Medicine in St. Louis
Luke E. Springer, Washington University School of Medicine in St. Louis
Antonina Akk, Washington University School of Medicine in St. Louis
Lihua Yang, Washington University School of Medicine in St. Louis
Mark J. Miller, Washington University School of Medicine in St. Louis
Christine T.N Pham, Washington University School of Medicine in St. Louis
Paul H. Schlesinger, Washington University School of Medicine in St. Louis
Samuel A. Wickline, University of South Florida

Journal

International Journal of Nanomedicine

Publication Date

2018

Volume

2018

Issue

13

Inclusive Pages

5187—5205

Document Type

Open Access Publication

DOI

10.2147/IJN.S168556

Rights and Permissions

Pan H, Palekar RU, Hou KK, Bacon J, Yan H, Springer LE, Akk A, Yang L, Miller MJ, Pham CTN, Schlesinger PH, Wickline SA. 2018. Anti-JNK2 peptide–siRNA nanostructures improve plaque endothelium and reduce thrombotic risk in atherosclerotic mice. International Journal of Nanomedicine. 2018(13):5187—5205. https://doi.org/10.2147/IJN.S168556.

Recommended Citation

Pan, Hua; Palekar, Rohun U.; Hou, Kirk K.; Bacon, John; Yan, Huimin; Springer, Luke E.; Akk, Antonina; Yang, Lihua; Miller, Mark J.; Pham, Christine T.N; Schlesinger, Paul H.; and Wickline, Samuel A., "Anti-JNK2 peptide–siRNA nanostructures improve plaque endothelium and reduce thrombotic risk in atherosclerotic mice." International Journal of Nanomedicine. 2018, 13. 5187—5205. (2018).
https://digitalcommons.wustl.edu/open_access_pubs/7214